Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the company will present ...

A profound transformation is taking place in therapeutic discovery, development, and delivery.2026 will be a pivotal year for ...

Nick Edwards, PhD, CEO of Potato, has a “burning desire” to speed up scientific discovery. In an interview with GEN, he explained how Potato’s AI “scientist,” named Tater, recently replicated a main ...

He Jiankui spent three years in prison after creating gene-edited babies. Now back at work, he sees a greater opening for ...

This massive reach explains why so many experts consider the web the single most influential invention of modern times. In ...

Researchers at the University of Hawaiʻi at Mānoa have developed new mouse models to study a key male fertility gene, ...

Just 54% of U.S. adults now say they drink alcohol, according to a Gallup Poll conducted this past summer. The 2025 figure ...

Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery ...

For the last two years, the cultivated meat industry has been experiencing growing pains. Many startups have shrunk, shut ...

Disruption of alternative splicing can generate abnormal mRNA variants, producing nonfunctional proteins or triggering ...

Anthropic CEO Dario Amodei on Monday laid out the startup’s vision for how AI could solve problems in healthcare and the life sciences, from speeding up drug approvals by streamlining clinical trial ...

The company in 2026 is seeking approval from global regulators for Casgevy and two cystic fibrosis drugs in younger patients.